Artificial intelligence in cardiovascular prevention: new ways will open new doors

Author:

Ciccarelli Michele1,Giallauria Francesco2,Carrizzo Albino13,Visco Valeria1,Silverio Angelo1,Cesaro Arturo4,Calabrò Paolo4,De Luca Nicola5,Mancusi Costantino5,Masarone Daniele6,Pacileo Giuseppe6,Tourkmani Nidal78,Vigorito Carlo2,Vecchione Carmine13

Affiliation:

1. Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Italy

2. Department of Translational Medical Sciences, Federico II University, Naples, Italy

3. Vascular Physiopathology Unit, IRCCS Neuromed, Pozzilli

4. Department of Translational Medical Sciences, University of Campania ‘Luigi Vanvitelli’, Naples, Italy

5. Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy

6. Heart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital Naples, Naples, Italy

7. Cardiology and Cardiac Rehabilitation Unit, ‘Mons. Giosuè Calaciura Clinic’, Catania, Italy

8. ABL, Guangzhou, China

Abstract

Prevention and effective treatment of cardiovascular disease are progressive issues that grow in tandem with the average age of the world population. Over recent decades, the potential role of artificial intelligence in cardiovascular medicine has been increasingly recognized because of the incredible amount of real-world data (RWD) regarding patient health status and healthcare delivery that can be collated from a variety of sources wherein patient information is routinely collected, including patient registries, clinical case reports, reimbursement claims and billing reports, medical devices, and electronic health records. Like any other (health) data, RWD can be analysed in accordance with high-quality research methods, and its analysis can deliver valuable patient-centric insights complementing the information obtained from conventional clinical trials. Artificial intelligence application on RWD has the potential to detect a patient's health trajectory leading to personalized medicine and tailored treatment. This article reviews the benefits of artificial intelligence in cardiovascular prevention and management, focusing on diagnostic and therapeutic improvements without neglecting the limitations of this new scientific approach.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference140 articles.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Artificial Intelligence Enhances Heart Surgeries;South East European Journal of Cardiology;2023-11-23

2. Interventions to Address Cardiovascular Risk in Obese Patients: Many Hands Make Light Work;Journal of Cardiovascular Development and Disease;2023-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3